Citigroup Inc Rocket Pharmaceuticals, Inc. Transaction History

Citigroup Inc

$150 Billion
Q1 2024

A detailed history of Citigroup Inc transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 285,143 shares of RCKT stock, worth $6.14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

285,143

Previous 90,254 215.93%

Holding current value

$6.14 Million

Previous $2.7 Million 184.06%

% of portfolio

0.01%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$26.16 - $30.74 $5.1 Million - $5.99 Million	194,889 Added 215.93%	285,143 $7.68 Million
Q4 2023 Feb 09, 2024	SELL	$16.78 - $31.94 $1.19 Million - $2.26 Million	-70,861 Reduced 43.98%	90,254 $2.7 Million
Q3 2023 Nov 09, 2023	BUY	$15.07 - $24.05 $1.13 Million - $1.81 Million	75,071 Added 87.25%	161,115 $3.3 Million
Q2 2023 Aug 10, 2023	SELL	$16.59 - $23.6 $2.72 Million - $3.86 Million	-163,726 Reduced 65.55%	86,044 $1.71 Million
Q1 2023 May 11, 2023	BUY	$15.79 - $22.6 $1.82 Million - $2.6 Million	115,216 Added 85.63%	249,770 $4.28 Million

Q4 2022 Feb 09, 2023	SELL	$15.5 - $22.76 $3.14 Million - $4.61 Million	-202,411 Reduced 60.07%	134,554 $2.63 Million
Q3 2022 Nov 10, 2022	SELL	$12.37 - $18.41 $888,537 - $1.32 Million	-71,830 Reduced 17.57%	336,965 $5.38 Million
Q2 2022 Aug 10, 2022	BUY	$7.96 - $16.64 $2.89 Million - $6.05 Million	363,367 Added 799.87%	408,795 $5.63 Million
Q1 2022 May 12, 2022	SELL	$13.16 - $23.68 $1.23 Million - $2.21 Million	-93,377 Reduced 67.27%	45,428 $721,000
Q4 2021 Feb 10, 2022	BUY	$21.52 - $36.02 $1.24 Million - $2.08 Million	57,676 Added 71.09%	138,805 $3.03 Million
Q3 2021 Nov 10, 2021	BUY	$27.42 - $48.97 $2.22 Million - $3.97 Million	81,129 New	81,129 $2.43 Million

Others Institutions Holding RCKT

# of Institutions

205

Shares Held

92.9M

Call Options Held

341K

Put Options Held

107K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.63B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account